Clot Digestion
Clot Digestion - Related Videos
08:58
An Enzymatic Method to Rescue Mesenchymal Stem Cells from Clotted Bone Marrow Samples
0 Views •
Cited by 2 •
2015
Mesenchymal stem cells are usually obtained from bone marrow and require expansion culture. When samples clot before processing, a protocol using the (enzymatic) thrombolytic drug urokinase can be applied to degrade the clot. Thus, cells are released and available for expansion culture. This protocol provides a rapid and inexpensive alternative to resampling.
02:51
UV-Visible Spectroscopy for Monitoring Fibrin Clot Formation
0 Views •
2025
This video demonstrates the use of a UV-visible spectrophotometer for monitoring insoluble fibrin clot formation as a function of the change in the solution turbidity. The UV-visible spectrophotometer measures the solution’s absorbance over time, which represents the turbidity change due to the insoluble fibrin clot formation.
03:31
Inducing Blood Clot Formation in the Mouse Brain Using a Photosensitive Dye
0 Views •
2025
Source: Talley Watts, L., et al. Rose Bengal Photothrombosis by Confocal Optical Imaging In Vivo: A Model of Single Vessel Stroke. J. Vis. Exp. (2015)This video demonstrates a technique to induce blood clot formation in a mouse brain. An anesthetized mouse with a cranial window and a thinned skull undergoes photothrombosis through the activation of a photosensitive dye using high-intensity light. This process generates reactive oxygen species, which damage the vessel walls and trigger clot...
09:45
Restriction Enzyme Digests
0 Views •
2023
Restriction enzymes or endonucleases recognize and cut DNA at a specific sequence. These enzymes occur naturally in bacteria as a defense against bacteriophages - viruses that infect bacteria. Bacterial restriction enzymes cut the invading bacteriophage DNA while leaving the bacterial genomic DNA unharmed due to addition of methyl groups. This video explains the basic principles of restriction enzymes including: how restriction enzymes are named and the types of recognition sites and...
01:16
Clot Retraction and Fibrinolysis
0 Views •
2024
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
FAQs
Tissue plasminogen activator, or tPA, initiates the process by converting plasminogen into plasmin. Plasmin then acts on the fibrin network that gives the clot structural stability, cleaving it into breakdown products. This sequence links enzyme activation to loss of clot architecture and ultimately supports restoration of vessel patency.
The conversion supplies the active enzyme required for fibrin breakdown. Plasminogen itself is a precursor, whereas plasmin performs the cleavage of the stabilizing fibrin network. Because this activation step precedes structural disassembly, examining it helps bioengineers connect enzymatic activity with the rate and extent of clot digestion in experimental systems.
Fibrin cleavage removes the network that stabilizes the clot, while platelets and other cellular components are subsequently cleared or redistributed. Their handling is therefore distinct from enzymatic fibrin breakdown. Considering both processes gives a more complete picture of clot resolution than measuring fibrin digestion alone, especially in engineered models of hemostasis.
As the fibrin scaffold is cleaved and clot components are cleared or redistributed, the obstruction can diminish, helping restore vessel patency. At the same time, the process contributes to regulation of hemostasis, the system that controls bleeding. This dual relevance makes clot digestion important for studying both vessel reopening and clot control.
Researchers can evaluate the process by quantifying digestion rates and measuring fibrin breakdown. These readouts provide complementary information: the rate describes how quickly the clot changes, while fibrin breakdown indicates what happens to its stabilizing network. Together, the measurements help compare experimental conditions and assess whether a treatment produces the intended outcome.
Bioengineering studies use clot digestion measurements to examine how effectively thrombolytic therapies promote fibrin breakdown and clot resolution. Tracking digestion rates provides an outcome-oriented way to compare treatment performance, while assessing fibrin loss shows whether the clot’s structural support is being dismantled. These evaluations can guide efforts to improve control of clot-related complications.
Engineered vascular models provide systems in which clot formation and dissolution can be reproduced for study. Within these models, investigators can examine fibrinolysis, quantify digestion rates, and measure fibrin breakdown under defined experimental conditions. The resulting information supports development of thrombolytic therapies and helps evaluate how blood-contacting medical devices may interact with clot-related processes.